» Articles » PMID: 27041121

Motivations of Children and Their Parents to Participate in Drug Research: a Systematic Review

Overview
Journal Eur J Pediatr
Specialty Pediatrics
Date 2016 Apr 5
PMID 27041121
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Information on motivations for research participation, may enable professionals to better tailor the process of recruitment and informed consent to the perspective of parents and children. Therefore, this systematic review assesses motivating and discouraging factors for children and their parents to decide to participate in clinical drug research. Studies were identified from searches in 6 databases. Two independent reviewers screened and selected relevant articles. Results were aggregated and presented by use of qualitative metasummary. 38 studies fulfilled the selection criteria and were of sufficient quality for inclusion in the qualitative metasummary. Most mentioned motivating factors for parents were: health benefit for child, altruism, trust in research, and relation to researcher. Most mentioned motivating factors for children were: personal health benefit, altruism and increasing comfort. Fear of risks, distrust in research, logistical aspects and disruption of daily life were mentioned most by parents as discouraging factors. Burden and disruption of daily life, feeling like a "guinea pig" and fear of risks were most mentioned as discouraging factors by children.

Conclusion: Paying attention to these motivating and discouraging factors of children and their parents during the recruitment and informed consent process in drug research increases the moral and instrumental value of informed consent.

What Is Known: • This systematic review pools the existing empirical literature on motivations of minors and their parents to consent or dissent to participation in clinical drug research. • The most mentioned motivating and discouraging factors for children and their parents to consent to participation in clinical drug research are identified aggregated and presented by use of qualitative metasummary. What is new: • This information can be used to adapt the research protocol, recruitment, and informed consent/assent process to the needs of children and their parents.

Citing Articles

Urban-Suburban Differences in Public Perspectives on Digitalizing Pediatric Research: Cross-Sectional Survey Study.

Fang H, Xian R, Li J, Li Y, Liu E, Zhao Y J Med Internet Res. 2025; 27():e60324.

PMID: 39773676 PMC: 11751655. DOI: 10.2196/60324.


Parental motivations and perceived barriers to participating in pediatric vaccine clinical trials: Findings from the OCV-S trial in Nepal.

Chapagain R, Adhikari S, Kunwar K, Thapa P, Maharjan J, Giri B Vaccine X. 2024; 21:100585.

PMID: 39686923 PMC: 11647661. DOI: 10.1016/j.jvacx.2024.100585.


Informed consent and risk communication challenges in antimicrobial clinical trials: a scoping review.

Shou Y, Yeo J, Pang A, Paterson D, Mo Y BMJ Open. 2024; 14(11):e082096.

PMID: 39581733 PMC: 11590817. DOI: 10.1136/bmjopen-2023-082096.


What motivates people with type 2 diabetes mellitus to participate in clinical trials from home?.

Kopanz J, Lagerwaard B, Beran M, Veldwijk J, Mader J, Pottler T Clin Transl Sci. 2024; 17(11):e70070.

PMID: 39575651 PMC: 11582682. DOI: 10.1111/cts.70070.


Mass spectrometry-based proteomic profiling of extracellular vesicle proteins in diabetic and non-diabetic ischemic stroke patients: a case-control study.

Qadri S, Sohail M, Akhtar N, Pir G, Yousif G, Pananchikkal S Front Mol Biosci. 2024; 11:1387859.

PMID: 38948080 PMC: 11211575. DOI: 10.3389/fmolb.2024.1387859.


References
1.
Baren J, Anicetti J, Ledesma S, Biros M, Lewis R . An approach to community consultation prior to initiating an emergency research study incorporating a waiver of informed consent. Acad Emerg Med. 1999; 6(12):1210-5. DOI: 10.1111/j.1553-2712.1999.tb00135.x. View

2.
Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7):e1000097. PMC: 2707599. DOI: 10.1371/journal.pmed.1000097. View

3.
Deatrick J, Angst D, Moore C . Parents' views of their children's participation in phase I oncology clinical trials. J Pediatr Oncol Nurs. 2002; 19(4):114-21. DOI: 10.1177/104345420201900402. View

4.
Miller V, Baker J, Leek A, Hizlan S, Rheingold S, Yamokoski A . Adolescent perspectives on phase I cancer research. Pediatr Blood Cancer. 2012; 60(5):873-8. PMC: 3538102. DOI: 10.1002/pbc.24326. View

5.
Brody J, Turner C, Annett R, Scherer D, Dalen J . Predicting adolescent asthma research participation decisions from a structural equations model of protocol factors. J Adolesc Health. 2012; 51(3):252-8. PMC: 3628807. DOI: 10.1016/j.jadohealth.2011.12.015. View